Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Broad Center for Mendelian Genomics, |
RCV001254714 | SCV001430784 | uncertain significance | Leber congenital amaurosis 13 | 2020-05-29 | criteria provided, single submitter | research | The heterozygous p.Ile121Thr variant in RDH12 was identified by our study in 1 individual with Leber congenital amaurosis, along with a likely pathogenic variant (phase unknown; PMID: 32014858). Please note that this variant has been identified by a collaborative research study and was also be submitted by Massachusetts Eye and Ear. This variant was absent from large population studies. This variant has been reported in ClinVar as likely pathogenic by Ocular Genomics Institute, Massachusetts Eye and Ear (Variation ID: 805930). Computational prediction tools and conservation analyses do not provide strong support for or against an impact to the protein. In summary, while there is some suspicion for a pathogenic role, the clinical significance of this variant is uncertain. ACMG/AMP Criteria applied: PM2 (Richards 2015). |
Ocular Genomics Institute, |
RCV000993756 | SCV001146950 | likely pathogenic | Retinitis pigmentosa | 2019-08-01 | no assertion criteria provided | clinical testing |